Targeting IL-23 in autoimmunity

Current Opinion in Investigational Drugs

Volumn 6, Issue 5, 2005, Pages 489-495

  Hölscher, Christoph ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Autoimmunity; IL 12; IL 12p40 homodimer; IL 23; Infection; T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P19; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN DERIVATIVE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELLULAR IMMUNITY; DRUG MECHANISM; DRUG TARGETING; HUMAN; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; INFLAMMATION; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; RECEPTORS, INTERLEUKIN;

EID: 18144407681     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM: Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med (2001) 345(15):1098-1104.
2. Ehlers S, Hölscher C: DTH-associated pathology. In: Topley and Wilson's Microbiology and Microbial Infections. Kaufmann S (Ed), Arnold Publishing, London, UK (2005):705-730.
3. Glimcher LH, Murphy KM: Lineage commitment in the immune system: The T helper lymphocyte grows up. Genes Dev (2000) 14(14):1693-1711.
4. Hölscher C: The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med Microbiol Immunol (Berl) (2004) 193(1):1-17.
5. Caspi RR: IL-12 in autoimmunity. Clin Immunol Immunopathol (1998) 88(1):4-13.
6. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, Blumenschein WM et al: IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity (2002) 16(6):779-790.
7. Gearing DP, Cosman D: Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell (1991) 66(11):9-10.
8. Schoenhaut DS, Chua AO, Wolitzky AG, Quinn PM, Dwyer CM, McComas W, Familletti PC, Gately MK, Gubler U: Cloning and expression of murine IL-12. J Immunol (1992) 148(11):3433-3440.
9. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G: The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J Exp Med (1996) 183(1):147-157.
10. Yoshida A, Koide Y, Uchijima M, Yoshida TO: IFN-γ induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochem Biophys Res Commun (1994) 198(3):857-861.
11. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U: A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc Natl Acad Sci USA (1996) 93(24):14002-14007.
12. Lankford CS, Frucht DM: A unique role for IL-23 in promoting cellular immunity. J Leukocyte Biol (2003) 73(1):49-56.
13. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F et al: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 13(5):715-725.
14. Desai BB, Quinn PM, Wolitzky AG, Mongini PK, Chizzonite R, Gately MK: IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol (1992) 148(10):3125-3132.
15. Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, Minetti LJ, Warrier RR, Presky DH, Levine JF, Gately MK et al: Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol (1994) 153(1):128-136.
16. Chua AO, Wilkinson VL, Presky DH, Gubler U: Cloning and characterization of a mouse IL-12 receptor-β component. J Immunol (1995) 155(9):4286-4294.
17. 2 and JAK kinases. J Biol Chem (1997) 272(9):6073-6077.
18. Parham C, Chirica M, Timans J, Valsberg E, Travis M, Cheung J, Pflanz S, Zhang R, Singh KP, Vega F, To W et al: A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J Immunol (2002) 168(11):5699-5708.
19. Jacobson NG, Szabo SJ, Guler ML, Gorham JD, Murphy KM: Regulation of interleukin-12 signal transduction during T helper phenotype development. Res Immunol (1995) 146(7-8):446-456.
20. Lucas S, Ghilardi N, Li J, de Sauvage FJ: IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through STAT1-dependent and -independent mechanisms. Proc Natl Acad Sci USA (2003) 100(125):15047-15052.
21. Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, Afkarian M, Murphy TL: Signaling and transcription in T helper development. Annu Rev Immunol (2000) 18:451-494.
22. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S et al: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature (2003) 421(6924):744-748.
23. Mattner F, Ozmen L, Podlaski FJ, Wilkinson VL, Presky DH, Gately MK, Alber G: Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor α-dependent shock. Infect Immun (1997) 65(11):4734-4737.
24. Becher B, Durell BG, Noelle RJ: Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest (2002) 110(4):493-497.
25. Gran B, Zhang GX, Yu S, Li J, Chen XH, Ventura ES, Kamoun M, Rostami A: IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol (2002) 169(12):7104-7110.
26. McIntyre KW, Shuster DJ, Gillooly KM, Warrier RR, Connaughton SE, Hall LB, Arp LH, Gately MK, Magram J: Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur J Immunol (1996) 26(12):2933-2938.
27. Steinman L: Multiple sclerosis: A two-stage disease. Nat Immunol (2001) 2(9):762-764.
28. Aloisi F, Ria F, Adorini L: Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes. Immunol Today (2000) 21(3):141-147.
29. Heremans H, Dillen C, Groenen M, Matthys P, Billiau A: Role of enDogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice. Eur Cytokine Netw (1999) 10(2):171-180.
30. Hölscher C, Atkinson RA, Arendse B, Brown N, Myburgh E, Alber G, Brombacher F: A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol (2001) 167(12):6957-6966.
31. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ: Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med (2003) 198(12):1951-1957.
32. Zhang GX, Gran B, Yu S, Li J, Siglienti I, Chen X, Kamoun M, Rostami A: Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-β2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J Immunol (2003) 170(4):2153-2160.
33. Zhang GX, Yu S, Gran B, Li J, Siglienti I, Chen X, Calida D, Ventura E, Kamoun M, Rostami A: Role of IL-12 receptor β1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis. J Immunol (2003) 171(9):4485-4492.
34. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med (2005) 201(2):233-240.
35. Nakae S, Nambu A, Sudo K, Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol (2003) 171(11):6173-6177.
36. Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ: IL-12 and IL-23: Master regulators of innate and adaptive immunity. Immunol Rev (2004) 202:96-105.
37. Chu CQ, Wittmer S, Dalton DK: Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med (2000) 192(1):123-128.
38. Vandenbroeck K, Alloza I, Gadina M, Matthys P: Inhibiting cytokines of the interleukin-12 family: Recent advances and novel challenges. J Pharm Pharmacol (2004) 56(2):145-160.
39. Uyttenhove C, Arendse B, Stroobant V, Brombacher F, Van Snick J: Development at an anti-IL-12 p40 auto-vaccine: Protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection. Eur J Immunol (2004) 34(12):3572-3581.
40. Hölscher C, Kohler G, Müller U, Mossmann H, Schaub GA, Brombacher F: Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in γ interferon receptor or inducible nitric oxide synthase. Infect Immun (1998) 66(3):1208-1215.
41. Muller U, Kohler G, Mossmann H, Schaub GA, Alber G, Di Santo JP, Brombacher F, Holscher C: IL-12-independent IFN-γ production by T cells in experimental Chagas' disease is mediated by IL-18. J Immunol (2001) 167(6):3346-3353.
42. Cooper AM, Kipnis A, Turner J, Magram J, Ferrante J, Orme IM: Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol (2002) 168(3):1322-1327.
43. Decken K, Kohler G, Palmer-Lehmann K, Wunderlin A, Mattner F, Magram J, Gately MK, Alber G: Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun (1998) 66(10):4994-5000.
44. Lehmann J, Bellmann S, Werner C, Schroder R, Schutze N, Alber G: IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis. J Immunol (2001) 167(9):5304-5315.
45. Lieberman LA, Cardillo F, Owyang AM, Rennick DM, Cua DJ, Kastelein RA, Hunter CA: IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J Immunol (2004) 173(3):1887-1893.